AVENTIS PHARMA S.A.

Crystalline forms of dimethoxy docetaxel and methods for preparing the same

Mutations of the parkin gene, compositions, methods and uses

Crystalline form of cabazitaxel and process for preparing the same

Solid pharmaceutical composition comprising telithromycin

Transgeneic animal expressing a multiple mutated form of presenilin 1

Crystalline forms of dimethoxy docetaxel and methods for preparing the same

Antitumoral use of cabazitaxel

Modified soluble FGF receptor Fc fusions method

Compositions for oral adminstration of active principles requiring masking of taste

Mutations of the parkin gene

Method for identifying an antagonist of guanine nucleotide releasing factor 1

Mutations of the parkin gene, compositions, methods and uses

Method of treating cancer with docetaxel and doxorubicin

Crystalline forms of dimethoxy docetaxel and methods for preparing the same

Modified yeasts and uses thereof, in particular for producing steroid derivatives

Method and intermediates for preparing 19-norsteroid compounds

Modified yeasts and uses thereof, in particular for producing steroid derivatives

Taxoid-based compositions

Yeast strains autonomously producing steroids

Modified soluble FGF receptor Fc fusions with improved biological activity

Yeast strains autonomously producing steroids

Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof

Cholesterol-producing yeast strains and uses thereof

Pyrrolo(2,3-b) pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors

Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof

Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them

Recombinant adenoviruses preparation and adenovirus banks

Pyridazinone kinase inhibitors

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

4-benzimidazol-2-ylpyridazin-3-one derivatives

Combination comprising combretastatin and anticancer agents

Bengamides with a substituted caprolactam cycle, method for the preparation thereof, compositions containing them and use thereof

Use of aminoindazole derivatives for the inhibition of tau phosphorylation

1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them

Benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as c-MET inhibitors

Method for affinity chromatography of antithrombin III

Variants of the PapM polypeptide of bacteria of the genus

7-substituted aza-indazoles, compositions containing same, production method and use thereof

Substituted pyrroles, compositions containing same, method for making same and use thereof

Fluorene derivatives, composition containing said derivatives and the use thereof

Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof

Substituted pyrrolopyridines, compositions containing them, manufacturing process therefor and use thereof

Method for preparing oestrogen derivatives

Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses

Isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities

Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Triazine derivatives, their preparation and therapeutic application thereof

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists

Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses

Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof

Bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors

Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof

Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use

Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases

Method for analyzing oligosaccharides from blood plasma

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Cytotoxic agents comprising new C-2 modified taxanes

Product, method and intermediates for the preparation of azetidine derivatives

Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses